All lobbying filings

W STRATEGIES, LLC

W STRATEGIES, LLC filed a Q2 report for ABBOTT LABORATORIES on July 20, 2026, reporting $50,000 in lobbying income.

Lobbying for ABBOTT LABORATORIES · A pharmaceuticals health care company.

All filings by W STRATEGIES, LLC · Everything ABBOTT LABORATORIES has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 1

HOUSE OF REPRESENTATIVES

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Issues related to infant formula access. Issues related to DMEPOS reimbursement by CMS. H.R.2300 - To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes.

Bills named in this filing 1

H.R. 2300
To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other pu…

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.